Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important INTRODUCTION

被引：0
|
作者：
Kircik, Leon H. [1 ,2 ,3 ,4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Indiana Sch Med, Indianapolis, IN 46202 USA
[3] Phys Skin Care PLLC, Louisville, KY 40217 USA
[4] Skin Sci PLLC, Louisville, KY 40217 USA
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2017年 / 16卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [41] Efficacy of PUVA therapy compared with biologics in moderate to severe chronic plaque psoriasis
    Inzinger, Martin
    Heschl, Bettina
    Weger, Wolfgang
    Hofer, Angelika
    Legat, Franz Josef
    Gruber-Wackernagel, Alexandra
    Salmhofer, Wolfgang
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S55 - S55
  • [42] Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management (vol 12, pg 1, 2022)
    Al-Janabi, A.
    Yiu, Z. Z. N.
    [J]. PSORIASIS-TARGETS AND THERAPY, 2022, 12 : 187 - 187
  • [43] Long-term safety of approved biologics for ulcerative colitis
    D'Amico, Ferdinando
    Parigi, Tommaso Lorenzo
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 807 - 816
  • [44] Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis
    de Miguel, Rebeca
    el-Azhary, Rokea
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (06) : 653 - 658
  • [45] Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
    Golhen, Klervi
    Winskill, Carolyn
    Theiler, Martin
    Buettcher, Michael
    Yeh, Yu-Hsin
    Zhang, Nancy
    Welzel, Tatjana
    Pfister, Marc
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [46] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T. N.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 509 - 519
  • [47] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E284 - E285
  • [48] Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
    Tyring, Stephen
    Gordon, Kenneth B.
    Poulin, Yves
    Langley, Richard G.
    Gottlieb, Alice B.
    Dunn, Meleana
    Jahreis, Angelika
    [J]. ARCHIVES OF DERMATOLOGY, 2007, 143 (06) : 719 - 726
  • [49] Long-term efficacy and safety of infliximab in the treatment of patients affected by psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Talamonti, M.
    Giunta, A.
    Costanzo, A.
    Chimenti, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 47 - 48
  • [50] Assessment of the long-term safety and efficacy of etanercept for the treatment of psoriasis in an adult Canadian population
    Papp, Kim
    Bissonnette, Robert
    Luong, Trinh
    Poulin, Yves
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB165 - AB165
12345